Cyprotex

www.cyprotex.com Profile page

Follow

Follow

Only registred members can create thier own customized alerts.

Help
Watchlist/Portfolio

Add to watchlist:
Only registered members can add into watchlist !

Register here !

Cyprotex is a preclinical discovery/development contract research organisation with a core focus
in analysing the ADME (absorption, distribution, metabolism and excretion) and pharmacokinetic properties
of potential new drugs.

Website:: http://www.cyprotex.com/
Phone:: +44 (0)1625 505 100
Address:: 15 Beech Lane, Macclesfield, Cheshire SK10 2DR.

Super Sector:: Pharmaceuticals & Biotechnology
Sector:: Pharmaceuticals & Biotechnology
Industry:: Pharmaceuticals
EPIC / Symbols:: LON:CRX

Print
Email

Email to a friend:

To: From: Name: Description:
Verification code
Enter the code from aboveRequired
RSS

Cyprotex RNS Press Releases

Page 1 of 14

03/05/12
Product Launch
22/03/12
Final Results
12/01/12
Pre-Closed Trading Update
16/12/11
Sygnature Discovery and Cyprotex Extend Alliance
09/11/11
Product Upgrade
07/11/11
Expansion of US Facility
04/10/11
Launch of New Genomic ADME Service
29/09/11
Board Change
27/09/11
Product Launch
25/08/11
Half Yearly Report

Cyprotex Articles

Page 1 of 1

02/09/10

Cyprotex Duo Map Out Ambitous Growth Plans

A chat with Tony Baxter and John Dootson reveals Cyprotex is in rude health - and has some ambitous plans to grow.

Proactive Newswires

Page 1 of 1

Connect with Facebook to view or add comments for this company

Additional Information

Share Price

5.50p

Change

0.00

Volume

101,743

Dividend

0

EPS

0.31

Shares

223.7 m

Offer

5.75

Bid

5.25

Avg. Vol

267,660

Yield

0.00

P/E

17.74

Mkt Cap

12.3 m
People interested in this company also viewed
ProactiveInvestors on Facebook

LOGIN

Cyprotex

Add to watchlist:

Sector: Pharmaceuticals & Biotechnology

Cyprotex Duo Map Out Ambitous Growth Plans